233 related articles for article (PubMed ID: 9293462)
1. Dexamethasone inhibits glioma-induced formation of capillary like structures in vitro and angiogenesis in vivo.
Wolff JE; Mölenkamp G; Hotfilder M; Laterra J
Klin Padiatr; 1997; 209(4):275-7. PubMed ID: 9293462
[TBL] [Abstract][Full Text] [Related]
2. [Angiogenesis induced by rat glioma cells in vitro].
Niida H; Minakawa T; Tanaka R
No Shinkei Geka; 1992 Nov; 20(11):1169-72. PubMed ID: 1280347
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
Saleh M; Stacker SA; Wilks AF
Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
[TBL] [Abstract][Full Text] [Related]
4. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
[TBL] [Abstract][Full Text] [Related]
5. Angiostatin suppresses malignant glioma growth in vivo.
Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
[TBL] [Abstract][Full Text] [Related]
6. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion.
Grobben B; De Deyn PP; Slegers H
Cell Tissue Res; 2002 Dec; 310(3):257-70. PubMed ID: 12457224
[TBL] [Abstract][Full Text] [Related]
7. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
Tanaka T; Cao Y; Folkman J; Fine HA
Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
[TBL] [Abstract][Full Text] [Related]
8. A tricistronic retroviral vector expressing natural antiangiogenic factors inhibits angiogenesis in vitro, but is not able to block tumor progression in vivo.
Ciafrè SA; Barillari G; Bongiorno-Borbone L; Wannenes F; Izquierdo M; Farace MG
Gene Ther; 2002 Feb; 9(4):297-302. PubMed ID: 11896469
[TBL] [Abstract][Full Text] [Related]
9. Endogenous growth inhibition of angiogenesis in brain tumors.
Kirsch M; Allende R; Black P; Schackert G
Cancer Metastasis Rev; 2007 Dec; 26(3-4):469-79. PubMed ID: 17960325
[TBL] [Abstract][Full Text] [Related]
10. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain.
Péoch M; Farion R; Hiou A; Le Bas JF; Pasquier B; Rémy C
Anticancer Res; 2002; 22(4):2147-51. PubMed ID: 12174896
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4.
Brockmann MA; Papadimitriou A; Brandt M; Fillbrandt R; Westphal M; Lamszus K
Clin Cancer Res; 2003 Oct; 9(12):4578-85. PubMed ID: 14555533
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of angiogenesis and growth of malignant gliomas in the athymic nude rat model: immunotherapy against "basic fibroblast growth factor"].
Nemati MN; Stan AC; Pütz KM; Pietsch T; Walter GF; Dietz H
Zentralbl Neurochir; 1996; 57(1):12-9. PubMed ID: 8900894
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.
Heiss JD; Papavassiliou E; Merrill MJ; Nieman L; Knightly JJ; Walbridge S; Edwards NA; Oldfield EH
J Clin Invest; 1996 Sep; 98(6):1400-8. PubMed ID: 8823305
[TBL] [Abstract][Full Text] [Related]
15. Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas.
Bian XW; Jiang XF; Chen JH; Bai JS; Dai C; Wang QL; Lu JY; Zhao W; Xin R; Liu MY; Shi JQ; Wang JM
Int Immunopharmacol; 2006 Jan; 6(1):90-9. PubMed ID: 16332517
[TBL] [Abstract][Full Text] [Related]
16. The human leukemic T-cell line, TALL-104, is cytotoxic to human malignant brain tumors and traffics through brain tissue: implications for local adoptive immunotherapy.
Kruse CA; Visonneau S; Kleinschmidt-DeMasters BK; Gup CJ; Gomez GG; Paul DB; Santoli D
Cancer Res; 2000 Oct; 60(20):5731-9. PubMed ID: 11059767
[TBL] [Abstract][Full Text] [Related]
17. Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis.
Winkler F; Kienast Y; Fuhrmann M; Von Baumgarten L; Burgold S; Mitteregger G; Kretzschmar H; Herms J
Glia; 2009 Sep; 57(12):1306-15. PubMed ID: 19191326
[TBL] [Abstract][Full Text] [Related]
18. Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis.
Abe T; Okamura K; Ono M; Kohno K; Mori T; Hori S; Kuwano M
J Clin Invest; 1993 Jul; 92(1):54-61. PubMed ID: 7686924
[TBL] [Abstract][Full Text] [Related]
19. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
Price A; Shi Q; Morris D; Wilcox ME; Brasher PM; Rewcastle NB; Shalinsky D; Zou H; Appelt K; Johnston RN; Yong VW; Edwards D; Forsyth P
Clin Cancer Res; 1999 Apr; 5(4):845-54. PubMed ID: 10213221
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
